Press release
Pharmaceutics and Novel Drug Delivery Systems 2019
18th Edition of International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery SystemsOctober 14-15, 2018| Warsaw,Poland
Pharmaceutics Conferences | Pharmaceutics 2019 Conferences | Novel Drug Delivery Conferences | Drug Delivery Conferences | NDDS Conferences | Drug Delivery 2019 Conferences | Pharmaceutical Conferences | Pharmaceutica Conferences | Pharma Conferences | Novel Drug Delivery 2019 Conferences | Top Pharmaceutics Conferences | Top Novel Drug Delivery Conferences | Best Drug Delivery Conferences | Best Pharmaceutics Conferences | Best Pharma Conferences
EuroSciCon invites all the participants from all over the world to attend “18th Edition of International Conference on Pharmaceutics and Novel Drug Delivery Systems ’’ during October 14-15, 2019 at Warsaw, Poland which includes prompt keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.
For further details: https://novel-drugdelivery-systems.euroscicon.com/
To know more about titles and topic: https://novel-drugdelivery-systems.euroscicon.com/call-for-abstracts
Pharmaceutics and Novel Drug Delivery Systems 2019 is a global overview the Theme: “Exploring the future of Pharma Industry through Pharma research, Nanomedicine and Drug Delivery Systems” is designed for professionals at all levels and career phases of the Pharmaceutical industry , Chemical Industry, Healthcare Industry, Medical Euipments who want to improve their understanding of what will drive and shape the future of the market. This will include senior executives, sales and marketing personnel, strategic planners, who will be benefit from a broad overview of the Pharmaceutical, chemical and healthcare industry. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries. This experience helps the conference to be an interactive forum and encourages a strong level of dialogue and discussion, thus maximising the benefits of attendance. This conference surely provides better information and insight into the development of the world Pharmaceutical industry, which in turn has enabled attendees to make better and more profitable decisions.
Keytopics: Pharmaceutics Conferences, Pharmaceutics Conferences 2019 , NDDS Conferences, Novel Drug Delivery Conferences ,Drug Delivery Conferences , American Pharmaceutics Conferences, European Drug Delivery Meetings, Asian Drug Delivery Events, Pharmaceutics Conferences Middle-East, Nanotechnology Drug Delivery Conferences , Drug Delivery Advances , Drug Delivery Challenges
Target Audience for Pharmaceutics 2019:
Eminent Scientists/ Research Professors in the field of Pharmaceutical, Chemistry, Chemical, Toxicology, Polymer, Clinical trials , Drug discovery, Drug development , Natural products Junior/Senior research fellows, Students, Directors of Pharmaceutical and Chemical research companies, Drug Discovery and Development, Pharmacovigilance Department, Regulatory affairs Members of Chemistry associations and exhibitors from Pharmaceutical, Chemical, Polymer Industry, Pharmaceutical equipment’s and Drug Delivery Devices.
Why to attend our Conference?
It promotes the positive contributions of Pharmaceutics and Novel Drug Delivery Systems by:
• Highlighting the advances, challenges in Pharmaceutics field and its positive contributions to society throughout its life cycle.
• Providing society with educational information to help raise awareness and correct misconceptions.
• Liaising with European and national institutions in policy matters to secure decisions based on accurate information.
• Communicating advances in drug delivery devices contribution to development, innovation and quality of life.
For queries, mail me: pharmaceutics@conferencesguide.org
Euroscicon
EuroSciCon Ltd 40 Bloomsbury Way Lower Ground Floor London, United Kingdom WC1A 2SE.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutics and Novel Drug Delivery Systems 2019 here
News-ID: 1335191 • Views: …
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…